TAIPEI, Taiwan Jan 13, 2024 – Canadian Intellectual Property Office has granted ImmunAdd the patent on the synthetic saponin molecules. “Innovation for Better Health” We are ImmunAdd.

TAIPEI, Taiwan Jun 28, 2022 – Taiwan Intellectual Property Office has granted ImmunAdd the patent on the synthetic saponin molecules. Innovation for Better Health We are ImmunAdd.

Our team was awarded the 18th National Award in the Academic Research for “the Discovery of IA05 as a Novel Saponin Adjuvant for Therapeutic Vaccine.” Our proprietary next generation saponin-based adjuvant platform has been awarded in the 18th National Award in the Academic Research.